The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Aspire Biopharma enrolls last patient in phase 1 trial of its oral transmucosal fast-acting high-dose aspirin formulation: Estero, Florida Thursday, June 26, 2025, 18:00 Hrs [IST] ...

Phase 1 Study Design The objectives of this Phase 1 single dose clinical study are to evaluate the safety, pharmacokinetics and pharmacodynamics of Aspire's sublingual aspirin powder when ...

The participants were an average 35 years old, with an average of one previous birth, and a pregravid body mass index (BMI) of 28 in the 162 mg group and 26 in the 81 mg group. There were similar ...

In a recent study published in the JAMA Oncology, researchers evaluate the association between aspirin use, lifestyle factors, and the risk of colorectal cancer (CRC). Study: Aspirin Use and ...

Among the group of participants deemed to have the most unhealthy risk factors, 2.12% of regular aspirin users developed colon cancer, compared to 3.4% of those who didn't take aspirin, the study ...

If a person chooses to regularly take aspirin, Nguyen said that "based on prior studies, the best evidence supports daily low-dose [81 mg] aspirin for prevention," rather than weekly doses of 325 ...

If a person chooses to regularly take aspirin, Nguyen said that "based on prior studies, the best evidence supports daily low-dose [81 mg] aspirin for prevention," rather than weekly doses of 325 ...

Regular aspirin use was defined as either two or more standard dose (325 mg) tablets per week or daily low-dose (81 mg) aspirin. Study participants were followed starting from an average age of 49 ...

Regular aspirin use was defined as either two or more standard dose (325 mg) tablets per week or daily low-dose (81 mg) aspirin. Study participants were followed starting from an average age of 49 ...

Regular aspirin use was defined as either two or more standard dose (325 mg) tablets per week or daily low-dose (81 mg) aspirin. Study participants were followed starting from an average age of 49 ...

THURSDAY, Aug. 1, 2024 (HealthDay News) -- It's long been known that a daily dose of low-dose aspirin helps keep colon cancer at bay. But new research suggests that those who benefit most are ...